Usana Health Sciences (USNA) closed at $14.04 on October 26, 2026, up 0.6% from the previous close, on volume of 186,747 shares (30-day average 176,604).
Data as of October 26, 2026.
No headlines found.
USANA Schedules Third Quarter 2026 Earnings Release and Conference Call
Business Wire (Mon, 12-Oct 4:30 PM ET)
USANA Health Sciences and University of Utah Athletics Announce New Partnership
PRNewswire (Wed, 7-Oct 7:07 AM ET)
USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
PRNewswire (Thu, 1-Oct 7:07 AM ET)
PRNewswire (Thu, 3-Sep 7:08 AM ET)
USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
PRNewswire (Tue, 1-Sep 7:06 AM ET)
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
PRNewswire (Mon, 17-Aug 7:13 AM ET)
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
PRNewswire (Wed, 5-Aug 7:03 AM ET)
USANA Health Sciences Reports Second Quarter 2026 Results
Business Wire (Tue, 4-Aug 4:05 PM ET)
New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow
PRNewswire (Thu, 30-Jul 7:04 AM ET)
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Usana Health Sciences trades on the NYSE stock market under the symbol USNA.
As of October 26, 2026, USNA stock price climbed to $14.04 with 186,747 million shares trading.
USNA has a beta of 0.06, meaning it tends to be less sensitive to market movements. USNA has a correlation of 0.00 to the broad based SPY ETF.
USNA has a market cap of $259.41 million. This is considered a Small Cap stock.
Last quarter Usana Health Sciences reported $223 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.50.
In the last 3 years, USNA traded as high as $55.45 and as low as $12.57.
The top ETF exchange traded funds that USNA belongs to (by Net Assets): VTI, DFSV, IWM, AVUV, DFAT.
USNA has underperformed the market in the last year with a price return of -31.9% while the SPY ETF gained +15.1%. USNA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -32.9% and -4.2%, respectively, while the SPY returned +3.9% and -1.7%, respectively.
USNA support price is $13.56 and resistance is $14.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USNA shares will trade within this expected range on the day.
